These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18612047)

  • 1. The Translational Research Working Group developmental pathways: introduction and overview.
    Hawk ET; Matrisian LM; Nelson WG; Dorfman GS; Stevens L; Kwok J; Viner J; Hautala J; Grad O;
    Clin Cancer Res; 2008 Sep; 14(18):5664-71. PubMed ID: 18612047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Translational Research Working Group developmental pathway for lifestyle alterations.
    Hawk ET; Greenwood A; Gritz ER; McTiernan A; Sellers T; Hursting SD; Leischow S; Grad O;
    Clin Cancer Res; 2008 Sep; 14(18):5707-13. PubMed ID: 18794079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Translational Research Working Group developmental pathway for image-based assessment modalities.
    Dorfman GS; Sullivan DC; Schnall MD; Matrisian LM;
    Clin Cancer Res; 2008 Sep; 14(18):5678-84. PubMed ID: 18794075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Translational Research Working Group developmental pathway for interventive devices.
    Dorfman GS; Lawrence TS; Matrisian LM;
    Clin Cancer Res; 2008 Sep; 14(18):5700-6. PubMed ID: 18794078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational Research Working Group developmental pathway for biospecimen-based assessment modalities.
    Srivastava S; Gray JW; Reid BJ; Grad O; Greenwood A; Hawk ET;
    Clin Cancer Res; 2008 Sep; 14(18):5672-7. PubMed ID: 18794074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Translational Research Working Group developmental pathway for anticancer agents (drugs or biologics).
    Schilsky RL; Gordon G; Gilmer TM; Courtneidge SA; Matrisian LM; Grad O; Nelson WG;
    Clin Cancer Res; 2008 Sep; 14(18):5685-91. PubMed ID: 18794076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational Research Working Group developmental pathway for immune response modifiers.
    Cheever MA; Schlom J; Weiner LM; Lyerly HK; Disis ML; Greenwood A; Grad O; Nelson WG;
    Clin Cancer Res; 2008 Sep; 14(18):5692-9. PubMed ID: 18794077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the editor. Translational Research Working Group roadmaps for cancer research.
    Bates SE
    Clin Cancer Res; 2008 Sep; 14(18):5663. PubMed ID: 18794073
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the future of oncology? National Cancer Institute initiatives to improve research, development, and implementation in cancer prevention and treatment.
    Hawk E; Viner JL
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S6-9. PubMed ID: 17178278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reengineering clinical research science: a focus on translational research.
    Ferrell CB
    Behav Modif; 2009 Jan; 33(1):7-23. PubMed ID: 18776172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the National Cancer Institute's clinical trials cooperative group program.
    Wallner PE
    J Am Coll Radiol; 2004 Nov; 1(11):865-6. PubMed ID: 17411719
    [No Abstract]   [Full Text] [Related]  

  • 14. A new vision for the study of benign prostate disease: the NIDDK Prostate Research Strategic Plan.
    Mullins C; Kaplan SA
    J Urol; 2009 Mar; 181(3):963-71. PubMed ID: 19150562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances at the Center for Cancer Research at the National Cancer Institute's Medical Oncology Branch.
    Giaccone G
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):443-4, 459. PubMed ID: 17679918
    [No Abstract]   [Full Text] [Related]  

  • 16. Signposts along the NIH roadmap for reengineering clinical research: lessons from the Clinical Research Networks initiative.
    Williams RL; Johnson SB; Greene SM; Larson EB; Green LA; Morris A; Confer D; Reaman G; Madigan R; Kahn J;
    Arch Intern Med; 2008 Sep; 168(17):1919-25. PubMed ID: 18809820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An observational study of health professionals' use of evidence to inform the development of clinical management tools.
    Hutchinson AM; Johnston L
    J Clin Nurs; 2008 Aug; 17(16):2203-11. PubMed ID: 18705739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matchmaking, metrics and money: a pathway to progress in translational research.
    Krontiris TG; Rubenson D
    Bioessays; 2008 Oct; 30(10):1025-9. PubMed ID: 18800381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The National Cancer Institute's Special Populations Networks for cancer awareness, research, and training.
    Clanton M
    Cancer; 2006 Oct; 107(8 Suppl):1931-2. PubMed ID: 16958025
    [No Abstract]   [Full Text] [Related]  

  • 20. Making clinical research a robust career path.
    Hayward AR
    Acad Med; 2009 Apr; 84(4):409-10. PubMed ID: 19318765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.